Max India Limited [MAXIND] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison

Max India Limited

NSE
Loading...

Indraprastha Medical Corporation Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Max India Limited wins in 4 metrics, Indraprastha Medical Corporation Ltd. wins in 14 metrics, with 0 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Max India Limited Indraprastha Medical Corporation Ltd. Better
P/E Ratio (TTM) -5.10 20.08 Indraprastha Medical Corporation Ltd.
Price-to-Book Ratio 1.74 5.57 Max India Limited
Debt-to-Equity Ratio 43.62 4.76 Indraprastha Medical Corporation Ltd.
PEG Ratio 0.31 -5.81 Max India Limited
EV/EBITDA -5.70 12.10 Indraprastha Medical Corporation Ltd.
Profit Margin (TTM) -80.64% 12.60% Indraprastha Medical Corporation Ltd.
Operating Margin (TTM) -59.39% 13.64% Indraprastha Medical Corporation Ltd.
EBITDA Margin (TTM) N/A 13.64% N/A
Return on Equity -39.14% 26.98% Indraprastha Medical Corporation Ltd.
Return on Assets (TTM) -22.18% 18.90% Indraprastha Medical Corporation Ltd.
Free Cash Flow (TTM) $-1.63B $1.20B Indraprastha Medical Corporation Ltd.
Dividend Yield N/A 0.95% N/A
1-Year Return -17.87% -5.84% Indraprastha Medical Corporation Ltd.
Price-to-Sales Ratio (TTM) 4.43 2.53 Indraprastha Medical Corporation Ltd.
Enterprise Value $6.63B $32.43B Indraprastha Medical Corporation Ltd.
EV/Revenue Ratio 3.60 2.23 Indraprastha Medical Corporation Ltd.
Gross Profit Margin (TTM) 70.23% 37.00% Max India Limited
Revenue per Share (TTM) $39 $158 Indraprastha Medical Corporation Ltd.
Earnings per Share (Diluted) $-29.75 $19.94 Indraprastha Medical Corporation Ltd.
Beta (Stock Volatility) 0.22 0.58 Max India Limited

Max India Limited vs Indraprastha Medical Corporation Ltd. Stock Performance Analysis

Loading Price Chart...

MAXIND
INDRAMEDCO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Max India Limited0.11%1.71%-2.06%11.53%-16.59%-13.59%
Indraprastha Medical Corporation Ltd.0.38%-0.95%4.95%-1.44%-21.11%-14.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Max India Limited-17.87%34.79%119.60%108.47%108.47%108.47%
Indraprastha Medical Corporation Ltd.-5.84%323.69%338.93%635.89%971.03%1,203.39%

Performance & Financial Health Analysis: Max India Limited vs Indraprastha Medical Corporation Ltd.

MetricMAXINDINDRAMEDCO
Market Information
Market Cap i₹8.17B₹37.31B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i50,115399,153
90 Day Avg. Volume i54,580289,583
Last Close₹158.62₹385.95
52 Week Range₹120.00 - ₹241.57₹342.00 - ₹640.85
% from 52W High-34.34%-39.78%
All-Time High₹338.00 (Jul 08, 2024)₹640.85 (Nov 06, 2025)
% from All-Time High-53.07%-39.78%
Growth Metrics
Quarterly Revenue Growth0.27%0.14%
Quarterly Earnings GrowthN/A0.25%
Financial Health
Profit Margin (TTM) i-0.81%0.13%
Operating Margin (TTM) i-0.59%0.14%
Return on Equity (TTM) i-0.39%0.27%
Debt to Equity (MRQ) i43.624.76
Cash & Liquidity
Book Value per Share (MRQ)₹89.40₹71.88
Cash per Share (MRQ)₹68.03₹50.31
Operating Cash Flow (TTM) i₹-1,558,828,000₹1.78B
Levered Free Cash Flow (TTM) i₹-1,403,920,000₹1.61B
Dividends
Last 12-Month Dividend Yield iN/A0.95%
Last 12-Month Dividend iN/A₹4.50

Valuation & Enterprise Metrics Analysis: Max India Limited vs Indraprastha Medical Corporation Ltd.

MetricMAXIND (Apr 24, 2026)INDRAMEDCO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-5.1020.08
Forward P/E iN/A18.63
PEG Ratio i0.31-5.81
Price to Sales (TTM) i4.432.53
Price to Book (MRQ) i1.745.57
Market Capitalization
Market Capitalization i₹8.17B₹37.31B
Enterprise Value i₹6.63B₹32.43B
Enterprise Value Metrics
Enterprise to Revenue i3.602.23
Enterprise to EBITDA i-5.7012.10
Risk & Other Metrics
Beta i0.220.58
Book Value per Share (MRQ) i₹89.40₹71.88

Financial Statements Comparison: Max India Limited vs Indraprastha Medical Corporation Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMAXIND (2025)INDRAMEDCO (2025)
Revenue/Sales i1.45B13.07B
Cost of Goods Sold i363.41M8.53B
COGS % of Revenue i25.0%65.3%
Gross Profit i1.09B4.54B
Gross Margin i75.0%34.7%
Research & Development iN/AN/A
Operating Income (EBIT) i-1.34B2.10B
Operating Margin i-92.2%16.1%
EBITDA i-973.77M2.64B
EBITDA Margin i-66.9%20.2%
Pre-Tax Income i-1.39B2.16B
Pre-Tax Income % of Revenue i-95.3%16.6%
Income Tax i18.11M553.30M
Income Tax % of Revenue i1.2%4.2%
Net Income (Profit) i-1.40B1.61B
Profit Margin i-96.5%12.3%

Balance Sheet & Liquidity Metrics

MetricMAXIND (2025)INDRAMEDCO (2025)
Cash & Equivalents i226.95M614.80M
Total Current Assets i2.61B4.31B
Total Current Assets % of Revenue i179.1%33.0%
Total Current Liabilities i1.65B1.79B
Total Current Liabilities % of Revenue i113.6%13.7%
Long-Term Debt i958.90M305.40M
Long-Term Debt % of Revenue i65.9%2.3%
Total Shareholders Equity i3.59B5.97B
Retained Earnings i-2.24B4.75B
Retained Earnings % of Revenue i-154.2%36.4%
Property, Plant & Equipment i1.53B2.60B

Cash Flow Statement Comparison

MetricMAXIND (2025)INDRAMEDCO (2025)
Operating Cash Flow i-1.56B1.78B
Operating Cash Flow % of Revenue i-107.1%13.6%
Capital Expenditures i-354.06M-363.30M
Free Cash Flow i-1.63B1.20B
FCF Margin i-112.4%9.2%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMAXINDINDRAMEDCO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i52.52M91.67M
Float Shares i24.68M41.01M
% Held by Insiders i59.61%55.41%
% Held by Institutions i0.07%0.57%
% Held by Public i40.32%44.02%

Dividend Analysis & Yield Comparison: Max India Limited vs Indraprastha Medical Corporation Ltd.

MetricMAXINDINDRAMEDCO
Last 12-Month Dividend iN/A₹4.50
Last 12-Month Dividend Yield iN/A0.95%
3-Year Avg Annual Dividend iN/A₹4.00
3-Year Avg Dividend Yield iN/A1.26%
3-Year Total Dividends iN/A₹12.00
Ex-Dividend DateN/ASep 18, 2025